https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
int CTSS scoring on Imaging could provide a timely and objective approach towards identifying patients requiring intensive care and hospitalisation. Combination of DAAs, Sofosbuvir and Ribavirin has been known as an effective treatment for HCV genotype 3. The aim of our study is to assess the efficacy of Sofosbuvir and Ribavirin in relapsed HCV genotype 3 patients. A cross-sectional retrospective analysis of hospital records between January 2015 and December 2016. Data was taken of only those patients who were followed
Like
Comment
Share
